Research & Development
Academic Report
Performance of plasma pTau217/Aβ42 ratio and pTau217 to predict Aβ pathology status defined by CSF testing in SPIN cohort
| Presented by: | Yuko Mori Sasaki1) , Roman Boeer2) , Javier Arranz3) , Daniel Alcolea3) |
| 1) Sysmex R&D Center Europe 2) Sysmex Europe SE 3) Department of Neurology, Sant Pau Memory Unit, IR SANT PAU, Hospital de la Santa Creu i Sant Pau – IIB Sant Pau |
|
| Academic conference: |
18th Clinical Trials on Alzheimer's Disease (CTAD) |
| Presentation Date: | December 3, 2025 |
- Information contained in the academic report is current as of the date of the announcement,
but may be subject to change without prior notice.